Viveve Medical, Inc. (VIVE)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2021 | -22.02 Million USD | -7.46% |
| 2020 | -21.23 Million USD | 54.54% |
| 2019 | -46.71 Million USD | 5.01% |
| 2018 | -49.18 Million USD | -34.27% |
| 2017 | -36.63 Million USD | -82.14% |
| 2016 | -20.11 Million USD | -61.85% |
| 2015 | -12.42 Million USD | -101.07% |
| 2014 | -6.18 Million USD | -276.62% |
| 2013 | 3.49 Million USD | 141.72% |
| 2012 | -8.38 Million USD | -45.66% |
| 2011 | -5.75 Million USD | -1040.2% |
| 2010 | -505 Thousand USD | 68.94% |
| 2009 | -1.62 Million USD | 16.19% |
| 2008 | -1.94 Million USD | 18.04% |
| 2007 | -2.36 Million USD | -279.45% |
| 2006 | 1.31 Million USD | 204.02% |
| 2005 | -1.26 Million USD | -52.22% |
| 2004 | -833 Thousand USD | -261.12% |
| 2003 | 517 Thousand USD | 69.51% |
| 2002 | 305 Thousand USD | 107.82% |
| 2001 | -3.9 Million USD | 47.34% |
| 2000 | -7.41 Million USD | -13.04% |
| 1999 | -6.55 Million USD | 60.51% |
| 1998 | -16.6 Million USD | -15.28% |
| 1997 | -14.4 Million USD | -860.0% |
| 1996 | -1.5 Million USD | -175.0% |
| 1995 | 2 Million USD | 176.92% |
| 1994 | -2.6 Million USD | 35.0% |
| 1993 | -4 Million USD | 85.77% |
| 1992 | -28.1 Million USD | -1121.74% |
| 1991 | -2.3 Million USD | -2200.0% |
| 1990 | -100 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2022 Q3 | -5.29 Million USD | 13.6% |
| 2022 Q2 | -6.12 Million USD | 0.87% |
| 2022 Q1 | -6.17 Million USD | 2.39% |
| 2021 Q2 | -4.05 Million USD | 30.06% |
| 2021 Q3 | -5.85 Million USD | -44.64% |
| 2021 Q4 | -6.32 Million USD | -8.02% |
| 2021 FY | -22.82 Million USD | -7.46% |
| 2021 Q1 | -5.79 Million USD | -21.79% |
| 2020 Q3 | -3.73 Million USD | 47.51% |
| 2020 Q1 | -6.31 Million USD | 57.41% |
| 2020 Q2 | -7.11 Million USD | -12.76% |
| 2020 Q4 | -4.75 Million USD | -27.31% |
| 2020 FY | -21.23 Million USD | 54.54% |
| 2019 Q3 | -7.95 Million USD | 18.18% |
| 2019 Q1 | -10.02 Million USD | 25.67% |
| 2019 Q4 | -14.81 Million USD | -86.24% |
| 2019 Q2 | -9.72 Million USD | 3.04% |
| 2019 FY | -46.71 Million USD | 5.01% |
| 2018 Q3 | -12.3 Million USD | -6.84% |
| 2018 Q1 | -12.66 Million USD | -23.91% |
| 2018 Q2 | -11.51 Million USD | 9.1% |
| 2018 FY | -49.18 Million USD | -34.27% |
| 2018 Q4 | -13.49 Million USD | -9.66% |
| 2017 Q1 | -6.69 Million USD | -15.03% |
| 2017 FY | -36.63 Million USD | -82.14% |
| 2017 Q4 | -10.22 Million USD | -6.33% |
| 2017 Q3 | -9.61 Million USD | 7.77% |
| 2017 Q2 | -10.42 Million USD | -55.71% |
| 2016 Q3 | -4.86 Million USD | 8.41% |
| 2016 Q4 | -5.82 Million USD | -19.53% |
| 2016 Q1 | -4.1 Million USD | -11.67% |
| 2016 Q2 | -5.31 Million USD | -29.47% |
| 2016 FY | -20.11 Million USD | -61.85% |
| 2015 Q2 | -3 Million USD | -19.1% |
| 2015 Q3 | -3.21 Million USD | -7.09% |
| 2015 Q1 | -2.52 Million USD | -44.84% |
| 2015 FY | -12.42 Million USD | -101.07% |
| 2015 Q4 | -3.67 Million USD | -14.23% |
| 2014 Q3 | -2.5 Million USD | -207.52% |
| 2014 FY | -6.18 Million USD | -276.62% |
| 2014 Q1 | -2.41 Million USD | -160.73% |
| 2014 Q2 | 2.32 Million USD | 196.56% |
| 2014 Q4 | -1.74 Million USD | 30.41% |
| 2013 Q3 | -609 Thousand USD | -107.66% |
| 2013 Q1 | -7.8 Million USD | -360.18% |
| 2013 FY | 3.49 Million USD | 141.72% |
| 2013 Q4 | 3.97 Million USD | 752.22% |
| 2013 Q2 | 7.94 Million USD | 201.77% |
| 2012 Q3 | -3.16 Million USD | -119.18% |
| 2012 Q2 | -1.44 Million USD | 78.7% |
| 2012 Q1 | -6.77 Million USD | -558.79% |
| 2012 FY | -8.38 Million USD | -45.66% |
| 2012 Q4 | 3 Million USD | 194.82% |
| 2011 Q4 | -1.02 Million USD | -156.61% |
| 2011 FY | -5.75 Million USD | -1040.2% |
| 2011 Q2 | -541 Thousand USD | 85.71% |
| 2011 Q1 | -3.78 Million USD | -1556.54% |
| 2011 Q3 | -401 Thousand USD | 25.88% |
| 2010 FY | -505 Thousand USD | 68.94% |
| 2010 Q3 | -5000.00 USD | 97.49% |
| 2010 Q1 | -561 Thousand USD | 6.97% |
| 2010 Q2 | -199 Thousand USD | 64.53% |
| 2010 Q4 | 260 Thousand USD | 5300.0% |
| 2009 Q3 | -358 Thousand USD | -16.61% |
| 2009 Q1 | -358 Thousand USD | -61.26% |
| 2009 Q4 | -603 Thousand USD | -68.44% |
| 2009 FY | -1.62 Million USD | 16.19% |
| 2009 Q2 | -307 Thousand USD | 14.25% |
| 2008 Q1 | -762 Thousand USD | 6.96% |
| 2008 FY | -1.94 Million USD | 18.04% |
| 2008 Q4 | -222 Thousand USD | 22.11% |
| 2008 Q3 | -285 Thousand USD | 57.53% |
| 2008 Q2 | -671 Thousand USD | 11.94% |
| 2007 FY | -2.36 Million USD | -279.45% |
| 2007 Q4 | -819 Thousand USD | -64.13% |
| 2007 Q2 | -363 Thousand USD | 47.08% |
| 2007 Q1 | -686 Thousand USD | -2005.56% |
| 2007 Q3 | -499 Thousand USD | -37.47% |
| 2006 Q2 | 72 Thousand USD | -94.42% |
| 2006 FY | 1.31 Million USD | 204.02% |
| 2006 Q1 | 1.29 Million USD | 425.19% |
| 2006 Q4 | 36 Thousand USD | 145.0% |
| 2006 Q3 | -80 Thousand USD | -211.11% |
| 2005 FY | -1.26 Million USD | -52.22% |
| 2005 Q4 | -397 Thousand USD | 0.0% |
| 2005 Q3 | -397 Thousand USD | -36.9% |
| 2005 Q1 | -184 Thousand USD | -190.2% |
| 2005 Q2 | -290 Thousand USD | -57.61% |
| 2004 Q3 | -436 Thousand USD | -73.71% |
| 2004 Q2 | -251 Thousand USD | 28.29% |
| 2004 Q1 | -350 Thousand USD | -572.97% |
| 2004 FY | -833 Thousand USD | -261.12% |
| 2004 Q4 | 204 Thousand USD | 146.79% |
| 2003 Q2 | 203 Thousand USD | 1253.33% |
| 2003 FY | 517 Thousand USD | 69.51% |
| 2003 Q3 | 225 Thousand USD | 10.84% |
| 2003 Q4 | 74 Thousand USD | -67.11% |
| 2003 Q1 | 15 Thousand USD | -92.86% |
| 2002 Q4 | 210 Thousand USD | -4.11% |
| 2002 FY | 305 Thousand USD | 107.82% |
| 2002 Q3 | 219 Thousand USD | 62.22% |
| 2002 Q2 | 135 Thousand USD | 152.12% |
| 2002 Q1 | -259 Thousand USD | 56.69% |
| 2001 Q4 | -598 Thousand USD | 39.47% |
| 2001 Q3 | -988 Thousand USD | 13.33% |
| 2001 Q2 | -1.14 Million USD | 3.06% |
| 2001 Q1 | -1.17 Million USD | 61.16% |
| 2001 FY | -3.9 Million USD | 47.34% |
| 2000 Q1 | -2.18 Million USD | -73.94% |
| 2000 Q2 | -882 Thousand USD | 59.6% |
| 2000 Q3 | -1.31 Million USD | -49.32% |
| 2000 Q4 | -3.02 Million USD | -129.92% |
| 2000 FY | -7.41 Million USD | -13.04% |
| 1999 Q4 | -1.25 Million USD | 10.36% |
| 1999 Q3 | -1.4 Million USD | 17.65% |
| 1999 Q2 | -1.7 Million USD | 22.73% |
| 1999 Q1 | -2.2 Million USD | 33.33% |
| 1999 FY | -6.55 Million USD | 60.51% |
| 1998 Q1 | -3.9 Million USD | 23.53% |
| 1998 Q3 | -4 Million USD | 25.93% |
| 1998 Q4 | -3.3 Million USD | 17.5% |
| 1998 FY | -16.6 Million USD | -15.28% |
| 1998 Q2 | -5.4 Million USD | -38.46% |
| 1997 Q2 | -2.7 Million USD | 10.0% |
| 1997 Q3 | -3.6 Million USD | -33.33% |
| 1997 FY | -14.4 Million USD | -860.0% |
| 1997 Q1 | -3 Million USD | -130.77% |
| 1997 Q4 | -5.1 Million USD | -41.67% |
| 1996 Q1 | 1.3 Million USD | -59.38% |
| 1996 Q4 | -1.3 Million USD | -116.67% |
| 1996 Q3 | -600 Thousand USD | 33.33% |
| 1996 Q2 | -900 Thousand USD | -169.23% |
| 1996 FY | -1.5 Million USD | -175.0% |
| 1995 Q2 | -600 Thousand USD | -400.0% |
| 1995 Q3 | -800 Thousand USD | -33.33% |
| 1995 Q4 | 3.2 Million USD | 500.0% |
| 1995 Q1 | 200 Thousand USD | 150.0% |
| 1995 FY | 2 Million USD | 176.92% |
| 1994 Q1 | -700 Thousand USD | 22.22% |
| 1994 FY | -2.6 Million USD | 35.0% |
| 1994 Q3 | -900 Thousand USD | -50.0% |
| 1994 Q4 | -400 Thousand USD | 55.56% |
| 1994 Q2 | -600 Thousand USD | 14.29% |
| 1993 Q4 | -900 Thousand USD | 0.0% |
| 1993 FY | -4 Million USD | 85.77% |
| 1993 Q1 | -900 Thousand USD | 10.0% |
| 1993 Q2 | -1.3 Million USD | -44.44% |
| 1993 Q3 | -900 Thousand USD | 30.77% |
| 1992 Q4 | -1 Million USD | 0.0% |
| 1992 Q1 | -25.1 Million USD | -4083.33% |
| 1992 Q3 | -1 Million USD | -11.11% |
| 1992 Q2 | -900 Thousand USD | 96.41% |
| 1992 FY | -28.1 Million USD | -1121.74% |
| 1991 Q4 | -600 Thousand USD | 0.0% |
| 1991 Q2 | -600 Thousand USD | -20.0% |
| 1991 Q3 | -600 Thousand USD | 0.0% |
| 1991 Q1 | -500 Thousand USD | 0.0% |
| 1991 FY | -2.3 Million USD | -2200.0% |
| 1990 FY | -100 Thousand USD | 0.0% |
| 1990 Q3 | - USD | 0.0% |
| 1990 Q2 | - USD | 100.0% |
| 1990 Q1 | -100 Thousand USD | 0.0% |
| 1990 Q4 | - USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -81.66 Million USD | 73.027% |
| Biotricity, Inc. | -14.09 Million USD | -56.283% |
| Cell MedX Corp. | -142.48 Thousand USD | -15359.063% |
| Dynatronics Corporation | -2.69 Million USD | -716.505% |
| Nemaura Medical Inc. | -14.14 Million USD | -55.737% |
| PetVivo Holdings, Inc. | -10.95 Million USD | -101.063% |
| RetinalGenix Technologies Inc. | -2.09 Million USD | -953.475% |
| Sonendo, Inc. | -60.91 Million USD | 63.842% |
| Telesis Bio, Inc. | -47.72 Million USD | 53.845% |
| Talis Biomedical Corporation | -62 Million USD | 64.477% |